CANCER IMMUNOL IMMUN 润色咨询

CANCER IMMUNOLOGY IMMUNOTHERAPY

出版年份：暂无数据 年文章数：2295 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：3.9% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=976789, encodeId=d4d59e67898a, content=请问这个杂志投稿后是所有author confirmed才会进入下一个流程吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ecec5428596, createdName=Ykkkk, createdTime=Fri Jun 25 14:11:44 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190585, encodeId=38d7119058505, content=请问已经under review11个月了，发邮件没有回复，这种情况怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220509/2b7facd4011a46e3ae2917f4bf3bf049/6328c748b7f0407f9efd69ce9b200021.jpg, createdBy=0c695270486, createdName=148202a4m20(暂无昵称), createdTime=Sun Feb 06 21:37:18 CST 2022, time=2022-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195316, encodeId=4ed8119531665, content=偏重的研究方向：免疫;肿瘤<br>经验分享：However, we noticed that the co-authors who are listed in the manuscript, are not listed in the metadata. <br>各位大师，请问这是啥意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3fc25491460, createdName=ms2000002013742439, createdTime=Sun Feb 20 11:43:15 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194438, encodeId=5acd1194438e7, content=为什么提交了之后收到了邮件，但是再进网站找不到提交记录，在哪里看提交记录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4406396697, createdName=ms8000000110405224, createdTime=Thu Feb 17 14:47:49 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183079, encodeId=f10911830e94b, content=请问各位Sci大神，这个杂志投稿后多久外审，1个月，2个月还是3个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/1d3a85981f6341c685aa69f9c27013bd/bc9a63edcff04dfda9c41946c5223f0b.jpg, createdBy=c7c95614650, createdName=ms2000001076054986, createdTime=Tue Jan 11 08:17:15 CST 2022, time=2022-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088395, encodeId=055f1088395b4, content=我们做研究时最常见或撰写的SCI文章类型是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088396, encodeId=c12a1088396d5, content=如何判断SCI文章类型？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059701, encodeId=00241059e01df, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2850.0<br>偏重的研究方向：免疫;肿瘤<br>经验分享：一审4个月，二审1个月，很慢，结果还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c1cb5501673, createdName=ms1000000647969526, createdTime=Tue Oct 12 10:49:35 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589301, encodeId=3c4e589301e9, content=2019年12月5日转投的，2020年4月19日正式接收，这个期刊从投稿到接收一般得小半年。<span class="quote">杨药师 2020-04-20 发表::<br>请问花了多长时间呢？</span><span class="quote">杨药师 2020-04-20 00:00:00 发表:<br>请问花了多长时间呢？</span>, beContent=杨药师 2020-04-20 发表:: 请问花了多长时间呢？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170414/IMG58F01DD73670E2168.jpg, createdBy=64071615229, createdName=gakkilovesky, createdTime=Mon Apr 20 00:00:00 CST 2020, time=2020-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015215, encodeId=67df101521577, content=请问各位大神，二审大概多久呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1f55081875, createdName=飞翔的阿吉, createdTime=Tue Sep 07 00:15:50 CST 2021, time=2021-09-07, status=1, ipAttribution=)]
    2021-06-25 Ykkkk

    请问这个杂志投稿后是所有author confirmed才会进入下一个流程吗？

    9

    展开9条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=976789, encodeId=d4d59e67898a, content=请问这个杂志投稿后是所有author confirmed才会进入下一个流程吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ecec5428596, createdName=Ykkkk, createdTime=Fri Jun 25 14:11:44 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190585, encodeId=38d7119058505, content=请问已经under review11个月了，发邮件没有回复，这种情况怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220509/2b7facd4011a46e3ae2917f4bf3bf049/6328c748b7f0407f9efd69ce9b200021.jpg, createdBy=0c695270486, createdName=148202a4m20(暂无昵称), createdTime=Sun Feb 06 21:37:18 CST 2022, time=2022-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195316, encodeId=4ed8119531665, content=偏重的研究方向：免疫;肿瘤<br>经验分享：However, we noticed that the co-authors who are listed in the manuscript, are not listed in the metadata. <br>各位大师，请问这是啥意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3fc25491460, createdName=ms2000002013742439, createdTime=Sun Feb 20 11:43:15 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194438, encodeId=5acd1194438e7, content=为什么提交了之后收到了邮件，但是再进网站找不到提交记录，在哪里看提交记录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4406396697, createdName=ms8000000110405224, createdTime=Thu Feb 17 14:47:49 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183079, encodeId=f10911830e94b, content=请问各位Sci大神，这个杂志投稿后多久外审，1个月，2个月还是3个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/1d3a85981f6341c685aa69f9c27013bd/bc9a63edcff04dfda9c41946c5223f0b.jpg, createdBy=c7c95614650, createdName=ms2000001076054986, createdTime=Tue Jan 11 08:17:15 CST 2022, time=2022-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088395, encodeId=055f1088395b4, content=我们做研究时最常见或撰写的SCI文章类型是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088396, encodeId=c12a1088396d5, content=如何判断SCI文章类型？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059701, encodeId=00241059e01df, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2850.0<br>偏重的研究方向：免疫;肿瘤<br>经验分享：一审4个月，二审1个月，很慢，结果还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c1cb5501673, createdName=ms1000000647969526, createdTime=Tue Oct 12 10:49:35 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589301, encodeId=3c4e589301e9, content=2019年12月5日转投的，2020年4月19日正式接收，这个期刊从投稿到接收一般得小半年。<span class="quote">杨药师 2020-04-20 发表::<br>请问花了多长时间呢？</span><span class="quote">杨药师 2020-04-20 00:00:00 发表:<br>请问花了多长时间呢？</span>, beContent=杨药师 2020-04-20 发表:: 请问花了多长时间呢？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170414/IMG58F01DD73670E2168.jpg, createdBy=64071615229, createdName=gakkilovesky, createdTime=Mon Apr 20 00:00:00 CST 2020, time=2020-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015215, encodeId=67df101521577, content=请问各位大神，二审大概多久呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1f55081875, createdName=飞翔的阿吉, createdTime=Tue Sep 07 00:15:50 CST 2021, time=2021-09-07, status=1, ipAttribution=)]
    2022-02-06 148202a4m20(暂无昵称)

    请问已经under review11个月了，发邮件没有回复，这种情况怎么办？

    2

    展开2条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=976789, encodeId=d4d59e67898a, content=请问这个杂志投稿后是所有author confirmed才会进入下一个流程吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ecec5428596, createdName=Ykkkk, createdTime=Fri Jun 25 14:11:44 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190585, encodeId=38d7119058505, content=请问已经under review11个月了，发邮件没有回复，这种情况怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220509/2b7facd4011a46e3ae2917f4bf3bf049/6328c748b7f0407f9efd69ce9b200021.jpg, createdBy=0c695270486, createdName=148202a4m20(暂无昵称), createdTime=Sun Feb 06 21:37:18 CST 2022, time=2022-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195316, encodeId=4ed8119531665, content=偏重的研究方向：免疫;肿瘤<br>经验分享：However, we noticed that the co-authors who are listed in the manuscript, are not listed in the metadata. <br>各位大师，请问这是啥意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3fc25491460, createdName=ms2000002013742439, createdTime=Sun Feb 20 11:43:15 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194438, encodeId=5acd1194438e7, content=为什么提交了之后收到了邮件，但是再进网站找不到提交记录，在哪里看提交记录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4406396697, createdName=ms8000000110405224, createdTime=Thu Feb 17 14:47:49 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183079, encodeId=f10911830e94b, content=请问各位Sci大神，这个杂志投稿后多久外审，1个月，2个月还是3个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/1d3a85981f6341c685aa69f9c27013bd/bc9a63edcff04dfda9c41946c5223f0b.jpg, createdBy=c7c95614650, createdName=ms2000001076054986, createdTime=Tue Jan 11 08:17:15 CST 2022, time=2022-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088395, encodeId=055f1088395b4, content=我们做研究时最常见或撰写的SCI文章类型是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088396, encodeId=c12a1088396d5, content=如何判断SCI文章类型？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059701, encodeId=00241059e01df, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2850.0<br>偏重的研究方向：免疫;肿瘤<br>经验分享：一审4个月，二审1个月，很慢，结果还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c1cb5501673, createdName=ms1000000647969526, createdTime=Tue Oct 12 10:49:35 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589301, encodeId=3c4e589301e9, content=2019年12月5日转投的，2020年4月19日正式接收，这个期刊从投稿到接收一般得小半年。<span class="quote">杨药师 2020-04-20 发表::<br>请问花了多长时间呢？</span><span class="quote">杨药师 2020-04-20 00:00:00 发表:<br>请问花了多长时间呢？</span>, beContent=杨药师 2020-04-20 发表:: 请问花了多长时间呢？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170414/IMG58F01DD73670E2168.jpg, createdBy=64071615229, createdName=gakkilovesky, createdTime=Mon Apr 20 00:00:00 CST 2020, time=2020-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015215, encodeId=67df101521577, content=请问各位大神，二审大概多久呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1f55081875, createdName=飞翔的阿吉, createdTime=Tue Sep 07 00:15:50 CST 2021, time=2021-09-07, status=1, ipAttribution=)]
    2022-02-20 ms2000002013742439

    偏重的研究方向：免疫;肿瘤
    经验分享：However, we noticed that the co-authors who are listed in the manuscript, are not listed in the metadata.
    各位大师，请问这是啥意思？

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=976789, encodeId=d4d59e67898a, content=请问这个杂志投稿后是所有author confirmed才会进入下一个流程吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ecec5428596, createdName=Ykkkk, createdTime=Fri Jun 25 14:11:44 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190585, encodeId=38d7119058505, content=请问已经under review11个月了，发邮件没有回复，这种情况怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220509/2b7facd4011a46e3ae2917f4bf3bf049/6328c748b7f0407f9efd69ce9b200021.jpg, createdBy=0c695270486, createdName=148202a4m20(暂无昵称), createdTime=Sun Feb 06 21:37:18 CST 2022, time=2022-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195316, encodeId=4ed8119531665, content=偏重的研究方向：免疫;肿瘤<br>经验分享：However, we noticed that the co-authors who are listed in the manuscript, are not listed in the metadata. <br>各位大师，请问这是啥意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3fc25491460, createdName=ms2000002013742439, createdTime=Sun Feb 20 11:43:15 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194438, encodeId=5acd1194438e7, content=为什么提交了之后收到了邮件，但是再进网站找不到提交记录，在哪里看提交记录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4406396697, createdName=ms8000000110405224, createdTime=Thu Feb 17 14:47:49 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183079, encodeId=f10911830e94b, content=请问各位Sci大神，这个杂志投稿后多久外审，1个月，2个月还是3个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/1d3a85981f6341c685aa69f9c27013bd/bc9a63edcff04dfda9c41946c5223f0b.jpg, createdBy=c7c95614650, createdName=ms2000001076054986, createdTime=Tue Jan 11 08:17:15 CST 2022, time=2022-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088395, encodeId=055f1088395b4, content=我们做研究时最常见或撰写的SCI文章类型是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088396, encodeId=c12a1088396d5, content=如何判断SCI文章类型？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059701, encodeId=00241059e01df, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2850.0<br>偏重的研究方向：免疫;肿瘤<br>经验分享：一审4个月，二审1个月，很慢，结果还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c1cb5501673, createdName=ms1000000647969526, createdTime=Tue Oct 12 10:49:35 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589301, encodeId=3c4e589301e9, content=2019年12月5日转投的，2020年4月19日正式接收，这个期刊从投稿到接收一般得小半年。<span class="quote">杨药师 2020-04-20 发表::<br>请问花了多长时间呢？</span><span class="quote">杨药师 2020-04-20 00:00:00 发表:<br>请问花了多长时间呢？</span>, beContent=杨药师 2020-04-20 发表:: 请问花了多长时间呢？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170414/IMG58F01DD73670E2168.jpg, createdBy=64071615229, createdName=gakkilovesky, createdTime=Mon Apr 20 00:00:00 CST 2020, time=2020-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015215, encodeId=67df101521577, content=请问各位大神，二审大概多久呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1f55081875, createdName=飞翔的阿吉, createdTime=Tue Sep 07 00:15:50 CST 2021, time=2021-09-07, status=1, ipAttribution=)]
    2022-02-17 ms8000000110405224

    为什么提交了之后收到了邮件，但是再进网站找不到提交记录，在哪里看提交记录

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=976789, encodeId=d4d59e67898a, content=请问这个杂志投稿后是所有author confirmed才会进入下一个流程吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ecec5428596, createdName=Ykkkk, createdTime=Fri Jun 25 14:11:44 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190585, encodeId=38d7119058505, content=请问已经under review11个月了，发邮件没有回复，这种情况怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220509/2b7facd4011a46e3ae2917f4bf3bf049/6328c748b7f0407f9efd69ce9b200021.jpg, createdBy=0c695270486, createdName=148202a4m20(暂无昵称), createdTime=Sun Feb 06 21:37:18 CST 2022, time=2022-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195316, encodeId=4ed8119531665, content=偏重的研究方向：免疫;肿瘤<br>经验分享：However, we noticed that the co-authors who are listed in the manuscript, are not listed in the metadata. <br>各位大师，请问这是啥意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3fc25491460, createdName=ms2000002013742439, createdTime=Sun Feb 20 11:43:15 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194438, encodeId=5acd1194438e7, content=为什么提交了之后收到了邮件，但是再进网站找不到提交记录，在哪里看提交记录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4406396697, createdName=ms8000000110405224, createdTime=Thu Feb 17 14:47:49 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183079, encodeId=f10911830e94b, content=请问各位Sci大神，这个杂志投稿后多久外审，1个月，2个月还是3个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/1d3a85981f6341c685aa69f9c27013bd/bc9a63edcff04dfda9c41946c5223f0b.jpg, createdBy=c7c95614650, createdName=ms2000001076054986, createdTime=Tue Jan 11 08:17:15 CST 2022, time=2022-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088395, encodeId=055f1088395b4, content=我们做研究时最常见或撰写的SCI文章类型是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088396, encodeId=c12a1088396d5, content=如何判断SCI文章类型？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059701, encodeId=00241059e01df, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2850.0<br>偏重的研究方向：免疫;肿瘤<br>经验分享：一审4个月，二审1个月，很慢，结果还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c1cb5501673, createdName=ms1000000647969526, createdTime=Tue Oct 12 10:49:35 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589301, encodeId=3c4e589301e9, content=2019年12月5日转投的，2020年4月19日正式接收，这个期刊从投稿到接收一般得小半年。<span class="quote">杨药师 2020-04-20 发表::<br>请问花了多长时间呢？</span><span class="quote">杨药师 2020-04-20 00:00:00 发表:<br>请问花了多长时间呢？</span>, beContent=杨药师 2020-04-20 发表:: 请问花了多长时间呢？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170414/IMG58F01DD73670E2168.jpg, createdBy=64071615229, createdName=gakkilovesky, createdTime=Mon Apr 20 00:00:00 CST 2020, time=2020-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015215, encodeId=67df101521577, content=请问各位大神，二审大概多久呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1f55081875, createdName=飞翔的阿吉, createdTime=Tue Sep 07 00:15:50 CST 2021, time=2021-09-07, status=1, ipAttribution=)]
    2022-01-11 ms2000001076054986

    请问各位Sci大神，这个杂志投稿后多久外审，1个月，2个月还是3个月

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=976789, encodeId=d4d59e67898a, content=请问这个杂志投稿后是所有author confirmed才会进入下一个流程吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ecec5428596, createdName=Ykkkk, createdTime=Fri Jun 25 14:11:44 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190585, encodeId=38d7119058505, content=请问已经under review11个月了，发邮件没有回复，这种情况怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220509/2b7facd4011a46e3ae2917f4bf3bf049/6328c748b7f0407f9efd69ce9b200021.jpg, createdBy=0c695270486, createdName=148202a4m20(暂无昵称), createdTime=Sun Feb 06 21:37:18 CST 2022, time=2022-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195316, encodeId=4ed8119531665, content=偏重的研究方向：免疫;肿瘤<br>经验分享：However, we noticed that the co-authors who are listed in the manuscript, are not listed in the metadata. <br>各位大师，请问这是啥意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3fc25491460, createdName=ms2000002013742439, createdTime=Sun Feb 20 11:43:15 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194438, encodeId=5acd1194438e7, content=为什么提交了之后收到了邮件，但是再进网站找不到提交记录，在哪里看提交记录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4406396697, createdName=ms8000000110405224, createdTime=Thu Feb 17 14:47:49 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183079, encodeId=f10911830e94b, content=请问各位Sci大神，这个杂志投稿后多久外审，1个月，2个月还是3个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/1d3a85981f6341c685aa69f9c27013bd/bc9a63edcff04dfda9c41946c5223f0b.jpg, createdBy=c7c95614650, createdName=ms2000001076054986, createdTime=Tue Jan 11 08:17:15 CST 2022, time=2022-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088395, encodeId=055f1088395b4, content=我们做研究时最常见或撰写的SCI文章类型是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088396, encodeId=c12a1088396d5, content=如何判断SCI文章类型？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059701, encodeId=00241059e01df, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2850.0<br>偏重的研究方向：免疫;肿瘤<br>经验分享：一审4个月，二审1个月，很慢，结果还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c1cb5501673, createdName=ms1000000647969526, createdTime=Tue Oct 12 10:49:35 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589301, encodeId=3c4e589301e9, content=2019年12月5日转投的，2020年4月19日正式接收，这个期刊从投稿到接收一般得小半年。<span class="quote">杨药师 2020-04-20 发表::<br>请问花了多长时间呢？</span><span class="quote">杨药师 2020-04-20 00:00:00 发表:<br>请问花了多长时间呢？</span>, beContent=杨药师 2020-04-20 发表:: 请问花了多长时间呢？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170414/IMG58F01DD73670E2168.jpg, createdBy=64071615229, createdName=gakkilovesky, createdTime=Mon Apr 20 00:00:00 CST 2020, time=2020-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015215, encodeId=67df101521577, content=请问各位大神，二审大概多久呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1f55081875, createdName=飞翔的阿吉, createdTime=Tue Sep 07 00:15:50 CST 2021, time=2021-09-07, status=1, ipAttribution=)]
    2021-12-29 乌云背后的幸福线

    我们做研究时最常见或撰写的SCI文章类型是什么？

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=976789, encodeId=d4d59e67898a, content=请问这个杂志投稿后是所有author confirmed才会进入下一个流程吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ecec5428596, createdName=Ykkkk, createdTime=Fri Jun 25 14:11:44 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190585, encodeId=38d7119058505, content=请问已经under review11个月了，发邮件没有回复，这种情况怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220509/2b7facd4011a46e3ae2917f4bf3bf049/6328c748b7f0407f9efd69ce9b200021.jpg, createdBy=0c695270486, createdName=148202a4m20(暂无昵称), createdTime=Sun Feb 06 21:37:18 CST 2022, time=2022-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195316, encodeId=4ed8119531665, content=偏重的研究方向：免疫;肿瘤<br>经验分享：However, we noticed that the co-authors who are listed in the manuscript, are not listed in the metadata. <br>各位大师，请问这是啥意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3fc25491460, createdName=ms2000002013742439, createdTime=Sun Feb 20 11:43:15 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194438, encodeId=5acd1194438e7, content=为什么提交了之后收到了邮件，但是再进网站找不到提交记录，在哪里看提交记录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4406396697, createdName=ms8000000110405224, createdTime=Thu Feb 17 14:47:49 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183079, encodeId=f10911830e94b, content=请问各位Sci大神，这个杂志投稿后多久外审，1个月，2个月还是3个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/1d3a85981f6341c685aa69f9c27013bd/bc9a63edcff04dfda9c41946c5223f0b.jpg, createdBy=c7c95614650, createdName=ms2000001076054986, createdTime=Tue Jan 11 08:17:15 CST 2022, time=2022-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088395, encodeId=055f1088395b4, content=我们做研究时最常见或撰写的SCI文章类型是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088396, encodeId=c12a1088396d5, content=如何判断SCI文章类型？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059701, encodeId=00241059e01df, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2850.0<br>偏重的研究方向：免疫;肿瘤<br>经验分享：一审4个月，二审1个月，很慢，结果还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c1cb5501673, createdName=ms1000000647969526, createdTime=Tue Oct 12 10:49:35 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589301, encodeId=3c4e589301e9, content=2019年12月5日转投的，2020年4月19日正式接收，这个期刊从投稿到接收一般得小半年。<span class="quote">杨药师 2020-04-20 发表::<br>请问花了多长时间呢？</span><span class="quote">杨药师 2020-04-20 00:00:00 发表:<br>请问花了多长时间呢？</span>, beContent=杨药师 2020-04-20 发表:: 请问花了多长时间呢？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170414/IMG58F01DD73670E2168.jpg, createdBy=64071615229, createdName=gakkilovesky, createdTime=Mon Apr 20 00:00:00 CST 2020, time=2020-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015215, encodeId=67df101521577, content=请问各位大神，二审大概多久呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1f55081875, createdName=飞翔的阿吉, createdTime=Tue Sep 07 00:15:50 CST 2021, time=2021-09-07, status=1, ipAttribution=)]
    2021-12-28 Mia

    如何判断SCI文章类型？

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=976789, encodeId=d4d59e67898a, content=请问这个杂志投稿后是所有author confirmed才会进入下一个流程吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ecec5428596, createdName=Ykkkk, createdTime=Fri Jun 25 14:11:44 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190585, encodeId=38d7119058505, content=请问已经under review11个月了，发邮件没有回复，这种情况怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220509/2b7facd4011a46e3ae2917f4bf3bf049/6328c748b7f0407f9efd69ce9b200021.jpg, createdBy=0c695270486, createdName=148202a4m20(暂无昵称), createdTime=Sun Feb 06 21:37:18 CST 2022, time=2022-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195316, encodeId=4ed8119531665, content=偏重的研究方向：免疫;肿瘤<br>经验分享：However, we noticed that the co-authors who are listed in the manuscript, are not listed in the metadata. <br>各位大师，请问这是啥意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3fc25491460, createdName=ms2000002013742439, createdTime=Sun Feb 20 11:43:15 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194438, encodeId=5acd1194438e7, content=为什么提交了之后收到了邮件，但是再进网站找不到提交记录，在哪里看提交记录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4406396697, createdName=ms8000000110405224, createdTime=Thu Feb 17 14:47:49 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183079, encodeId=f10911830e94b, content=请问各位Sci大神，这个杂志投稿后多久外审，1个月，2个月还是3个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/1d3a85981f6341c685aa69f9c27013bd/bc9a63edcff04dfda9c41946c5223f0b.jpg, createdBy=c7c95614650, createdName=ms2000001076054986, createdTime=Tue Jan 11 08:17:15 CST 2022, time=2022-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088395, encodeId=055f1088395b4, content=我们做研究时最常见或撰写的SCI文章类型是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088396, encodeId=c12a1088396d5, content=如何判断SCI文章类型？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059701, encodeId=00241059e01df, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2850.0<br>偏重的研究方向：免疫;肿瘤<br>经验分享：一审4个月，二审1个月，很慢，结果还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c1cb5501673, createdName=ms1000000647969526, createdTime=Tue Oct 12 10:49:35 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589301, encodeId=3c4e589301e9, content=2019年12月5日转投的，2020年4月19日正式接收，这个期刊从投稿到接收一般得小半年。<span class="quote">杨药师 2020-04-20 发表::<br>请问花了多长时间呢？</span><span class="quote">杨药师 2020-04-20 00:00:00 发表:<br>请问花了多长时间呢？</span>, beContent=杨药师 2020-04-20 发表:: 请问花了多长时间呢？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170414/IMG58F01DD73670E2168.jpg, createdBy=64071615229, createdName=gakkilovesky, createdTime=Mon Apr 20 00:00:00 CST 2020, time=2020-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015215, encodeId=67df101521577, content=请问各位大神，二审大概多久呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1f55081875, createdName=飞翔的阿吉, createdTime=Tue Sep 07 00:15:50 CST 2021, time=2021-09-07, status=1, ipAttribution=)]
    2021-10-12 ms1000000647969526

    审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2850.0
    偏重的研究方向：免疫;肿瘤
    经验分享：一审4个月，二审1个月，很慢，结果还可以。

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=976789, encodeId=d4d59e67898a, content=请问这个杂志投稿后是所有author confirmed才会进入下一个流程吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ecec5428596, createdName=Ykkkk, createdTime=Fri Jun 25 14:11:44 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190585, encodeId=38d7119058505, content=请问已经under review11个月了，发邮件没有回复，这种情况怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220509/2b7facd4011a46e3ae2917f4bf3bf049/6328c748b7f0407f9efd69ce9b200021.jpg, createdBy=0c695270486, createdName=148202a4m20(暂无昵称), createdTime=Sun Feb 06 21:37:18 CST 2022, time=2022-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195316, encodeId=4ed8119531665, content=偏重的研究方向：免疫;肿瘤<br>经验分享：However, we noticed that the co-authors who are listed in the manuscript, are not listed in the metadata. <br>各位大师，请问这是啥意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3fc25491460, createdName=ms2000002013742439, createdTime=Sun Feb 20 11:43:15 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194438, encodeId=5acd1194438e7, content=为什么提交了之后收到了邮件，但是再进网站找不到提交记录，在哪里看提交记录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4406396697, createdName=ms8000000110405224, createdTime=Thu Feb 17 14:47:49 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183079, encodeId=f10911830e94b, content=请问各位Sci大神，这个杂志投稿后多久外审，1个月，2个月还是3个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/1d3a85981f6341c685aa69f9c27013bd/bc9a63edcff04dfda9c41946c5223f0b.jpg, createdBy=c7c95614650, createdName=ms2000001076054986, createdTime=Tue Jan 11 08:17:15 CST 2022, time=2022-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088395, encodeId=055f1088395b4, content=我们做研究时最常见或撰写的SCI文章类型是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088396, encodeId=c12a1088396d5, content=如何判断SCI文章类型？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059701, encodeId=00241059e01df, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2850.0<br>偏重的研究方向：免疫;肿瘤<br>经验分享：一审4个月，二审1个月，很慢，结果还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c1cb5501673, createdName=ms1000000647969526, createdTime=Tue Oct 12 10:49:35 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589301, encodeId=3c4e589301e9, content=2019年12月5日转投的，2020年4月19日正式接收，这个期刊从投稿到接收一般得小半年。<span class="quote">杨药师 2020-04-20 发表::<br>请问花了多长时间呢？</span><span class="quote">杨药师 2020-04-20 00:00:00 发表:<br>请问花了多长时间呢？</span>, beContent=杨药师 2020-04-20 发表:: 请问花了多长时间呢？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170414/IMG58F01DD73670E2168.jpg, createdBy=64071615229, createdName=gakkilovesky, createdTime=Mon Apr 20 00:00:00 CST 2020, time=2020-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015215, encodeId=67df101521577, content=请问各位大神，二审大概多久呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1f55081875, createdName=飞翔的阿吉, createdTime=Tue Sep 07 00:15:50 CST 2021, time=2021-09-07, status=1, ipAttribution=)]
    2020-04-20 gakkilovesky

    2019年12月5日转投的，2020年4月19日正式接收，这个期刊从投稿到接收一般得小半年。杨药师 2020-04-20 发表::
    请问花了多长时间呢？    杨药师 2020-04-20 00:00:00 发表:
    请问花了多长时间呢？

    杨药师 2020-04-20 发表:: 请问花了多长时间呢？

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=976789, encodeId=d4d59e67898a, content=请问这个杂志投稿后是所有author confirmed才会进入下一个流程吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ecec5428596, createdName=Ykkkk, createdTime=Fri Jun 25 14:11:44 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190585, encodeId=38d7119058505, content=请问已经under review11个月了，发邮件没有回复，这种情况怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220509/2b7facd4011a46e3ae2917f4bf3bf049/6328c748b7f0407f9efd69ce9b200021.jpg, createdBy=0c695270486, createdName=148202a4m20(暂无昵称), createdTime=Sun Feb 06 21:37:18 CST 2022, time=2022-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195316, encodeId=4ed8119531665, content=偏重的研究方向：免疫;肿瘤<br>经验分享：However, we noticed that the co-authors who are listed in the manuscript, are not listed in the metadata. <br>各位大师，请问这是啥意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3fc25491460, createdName=ms2000002013742439, createdTime=Sun Feb 20 11:43:15 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194438, encodeId=5acd1194438e7, content=为什么提交了之后收到了邮件，但是再进网站找不到提交记录，在哪里看提交记录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4406396697, createdName=ms8000000110405224, createdTime=Thu Feb 17 14:47:49 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183079, encodeId=f10911830e94b, content=请问各位Sci大神，这个杂志投稿后多久外审，1个月，2个月还是3个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/1d3a85981f6341c685aa69f9c27013bd/bc9a63edcff04dfda9c41946c5223f0b.jpg, createdBy=c7c95614650, createdName=ms2000001076054986, createdTime=Tue Jan 11 08:17:15 CST 2022, time=2022-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088395, encodeId=055f1088395b4, content=我们做研究时最常见或撰写的SCI文章类型是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088396, encodeId=c12a1088396d5, content=如何判断SCI文章类型？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059701, encodeId=00241059e01df, content=审稿速度:6.0 | 投稿命中率:50.0 | 版面费用:2850.0<br>偏重的研究方向：免疫;肿瘤<br>经验分享：一审4个月，二审1个月，很慢，结果还可以。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c1cb5501673, createdName=ms1000000647969526, createdTime=Tue Oct 12 10:49:35 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589301, encodeId=3c4e589301e9, content=2019年12月5日转投的，2020年4月19日正式接收，这个期刊从投稿到接收一般得小半年。<span class="quote">杨药师 2020-04-20 发表::<br>请问花了多长时间呢？</span><span class="quote">杨药师 2020-04-20 00:00:00 发表:<br>请问花了多长时间呢？</span>, beContent=杨药师 2020-04-20 发表:: 请问花了多长时间呢？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170414/IMG58F01DD73670E2168.jpg, createdBy=64071615229, createdName=gakkilovesky, createdTime=Mon Apr 20 00:00:00 CST 2020, time=2020-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015215, encodeId=67df101521577, content=请问各位大神，二审大概多久呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1f55081875, createdName=飞翔的阿吉, createdTime=Tue Sep 07 00:15:50 CST 2021, time=2021-09-07, status=1, ipAttribution=)]
    2021-09-07 飞翔的阿吉

    请问各位大神，二审大概多久呢？

    2

    展开2条回复
共143条页码: 2/15页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分